Insider · CIK 0002016256
Richard David Abbott
Files at CODX (Co-Diagnostics, Inc.). First filing -, latest -.
In brief
Richard David Abbott files SEC Form 4 as president at CODX (Co-Diagnostics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard David Abbott has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +1,890 | $0.00 | $0 | 4,097 | May 27, 2026 |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -680 | $5.07 | $3,448 | 3,417 | May 27, 2026 |
| May 23, 2026 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -1,890 | $0.00 | $0 | 7,903 | May 27, 2026 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +56,667 | $0.00 | $0 | 83,402 | Nov 24, 2025 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -17,200 | $0.35 | $6,020 | 66,202 | Nov 24, 2025 |
| Nov 23, 2025 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -56,667 | $0.00 | $0 | 293,771 | Nov 24, 2025 |
| Aug 13, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Restricted Stock Unitsderivative | +220,000 | $0.00 | $0 | 350,438 | Aug 15, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 33,915 | May 27, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -7,180 | $0.24 | $1,723 | 26,735 | May 27, 2025 |
| May 23, 2025 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -20,000 | $0.00 | $0 | 130,438 | May 27, 2025 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 20,000 | Nov 25, 2024 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | DDisposition to issuer Common Stock | -6,085 | $1.01 | $6,146 | 13,915 | Nov 25, 2024 |
| Nov 23, 2024 | CODX Co-Diagnostics, Inc. | MOption exercise Restricted Stock Unitderivative | -20,000 | $0.00 | $0 | 150,438 | Nov 25, 2024 |
Questions about Richard David Abbott
Answered from the filings on this page, as of the latest one.
Is Richard David Abbott buying or selling?
Richard David Abbott has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard David Abbott's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard David Abbott has 0.
Where does Richard David Abbott file Form 4?
Richard David Abbott has filed Form 4 at CODX (Co-Diagnostics, Inc.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.